Medicare Part D Could Alleviate “Bias” In Formulary Decisions
Executive Summary
The use of pharmacy & therapeutics committees under the Medicare Part D drug benefit will help alleviate the bias sometimes seen in managed care decision making, Formulary Resources consultant Peter Penna suggested during the National Association of Chain Drug Stores' Medicare Prescription Drugs and Reform Conference in Baltimore March 3